Researchers conducted a cohort study to assess the frequency at which environmental shedding of methicillin-resistant Staphylococcus aureus occurs during inpatient and outpatient appointments.
The purpose of the study was to compare a composite clinical failure outcome of 60-day readmission, 60-day recurrence, and mortality in patients treated for MRSA with dual therapy vs those de-escalated to monotherapy.
There is a low incidence of second PJI in patients with bacteremia or hematogenous periprosthetic joint infection with concomitant prosthetic implants.
Four medical societies have come together to publish an updated consensus guideline on dosing and monitoring vancomycin for the treatment of serious MRSA infections.
In immunocompromised adults, community-acquired pneumonia should be treated by a multidisciplinary team of physicians.
Treatment with daptomycin for bacteremia caused by methicillin-resistant Staphylococcus aureus complicated by septic pulmonary emboli was found to have a success rate comparable to daptomycin-ceftaroline fosamil.
Investigators evaluated changes in the microbiology of osteomyelitis over a 10-year period, including infection with multidrug-resistant bacteria and susceptibility of antimicrobial regimens.
The association of S aureus with food sensitization and allergy could influence interventions aimed at inducing and maintaining tolerance to food allergens in eczematous infants.
Children with S aureus are more likely to have persistent egg, peanut allergy independent of eczema severity.
Time to blood culture positivity (TTP) provided reliable information on the risk for infective endocarditis (IE) in patients with Staphylococcus aureus bacteraemia.
